In this article we bring you some of the most important news coverage of this topic in the last few months, highlighting latest research, formulation development and how product launches are adapting around these drivers.
Probiotics is such a major trend that it has really filled a significant space in the Cosmetics Design archives of the past few months, so this is just a selection of the most pertinent stories.
Probiotic ingredients play their part in anti-pollution
Probiotic ingredient and formulations have been playing a growing part in the fast evolving anti-pollution trend, thanks to the part these type of ingredients can play in helping to protect the skin’s surface.
Earlier this month Cosmetics Design Europe published a two-part article authored by Lucy Whitehouse detailing how this trend has developed.
The first article focuses on the claims around anti-pollution and probiotic-inspired ingredients, while the second part of the article goes into more details about what is happening with respect to both ingredient and skin care brand claims in this space.
Solid research into microbiome in skin care
This article highlights how JooMo, one of the key brands is making strides in the microbiome-related skin care trend, having announced the completion of what it calls the ‘first ever clinical trials into the effect of everyday cosmetics on the skin microbiome’.
Undertaken at the Medical University of Graz, Austria, the pilot research study’s results are set to be published in a forthcoming scientific paper, the company says.
Only very limited details have been released by JooMo ahead of the paper.
As part of these, the company states that it believes the new pilot study supports the central conclusion of its earlier 2017 study, that microbial biodiversity is the only reliable measure of skin health.
Multinationals want a slice of the microbiome pie
On the back of Unilever’s announcement that Unilever Ventures was taking a stake in microbiome player Gallinée, Cosmetics Design obtained an exclusive interview with Gallinée's founder to find out more.
The investment is Unilever Ventures’ inaugural foray into microbiome-based products, according to Gallinée, which describes itself as ‘the first personal care brand to focus exclusively on the growing science of the human bacterial ecosystem’.
Unilever Ventures is the venture capital and private equity arm of Unilever. Its investment, along with other strategic partners, will be used to develop the Gallinée team, extend the range and finance R&D.